Dr Davina M Lujan, MD | |
250 Route 4, Suite 203, Hagatna, GU 96910-7110 | |
(671) 475-6500 | |
Not Available |
Full Name | Dr Davina M Lujan |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 34 Years |
Location | 250 Route 4, Hagatna, Guam |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003850462 | NPI | - | NPPES |
M-1053 | Other | GU | MEDICAL LICENSE |
H104727 | Other | GU | MEDICARE PTAN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | M-1053 (Guam) | Primary |
Entity Name | Guam Urgent Care |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1841628682 PECOS PAC ID: 3577796531 Enrollment ID: O20140429001315 |
News Archive
There is no significant difference between an over-the-counter decongestant and a prescription medication that costs almost four times as much in relieving hay fever symptoms, report researchers from the University of Chicago in the February issue of Archives of Otolaryngology - Head & Neck Surgery.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins for the treatment of diseases of the prostate and cancer, and Warburg Pincus, a leading global private equity firm, today jointly announced that they have entered into an Investment Agreement.
Roche announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Davina M Lujan, MD 250 Route 4, Suite 203, Hagatna, GU 96910-7110 Ph: (671) 475-6500 | Dr Davina M Lujan, MD 250 Route 4, Suite 203, Hagatna, GU 96910-7110 Ph: (671) 475-6500 |
News Archive
There is no significant difference between an over-the-counter decongestant and a prescription medication that costs almost four times as much in relieving hay fever symptoms, report researchers from the University of Chicago in the February issue of Archives of Otolaryngology - Head & Neck Surgery.
Teva Pharmaceutical Industries Ltd. and Active Biotech today announced the presentation of Phase III clinical and pre-clinical data, which collectively demonstrate that once-daily oral laquinimod modulates the pathological processes of multiple sclerosis to impact disease activity, disability progression and brain volume loss.
Protox Therapeutics Inc., a leader in the development of receptor targeted fusion proteins for the treatment of diseases of the prostate and cancer, and Warburg Pincus, a leading global private equity firm, today jointly announced that they have entered into an Investment Agreement.
Roche announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.
› Verified 9 days ago